A Phase II Open-Label, Two Arm Trial To Evaluate The Eff
A Phase Ii Open-Label, Two Arm Trial To Evaluate The Eff | |
|---|---|
| Sponsor(s) | Pfizer |
| Principal Investigator(s) | Fadlo R Khuri, MD, FACP |
| Dates | 9/03/2008 - 1/31/2012 |
A Phase Ii Open-Label, Two Arm Trial To Evaluate The Eff | |
|---|---|
| Sponsor(s) | Pfizer |
| Principal Investigator(s) | Fadlo R Khuri, MD, FACP |
| Dates | 9/03/2008 - 1/31/2012 |
